Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

You might go to Pocono Raceway for the action, but you might leave with something far more valuable. Man Cave Health is set ...

Symptoms linked to urinary or sexual health often carry an element of embarrassment, making men less likely to discuss them ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

Approximately one in eight men across the United Kingdom receives a prostate cancer diagnosis each year, making it the most ...

A research team at Kanazawa University, led by Professor Atsushi Mizokami, Associate Professor Koji Izumi and Specially ...

No, not everyone with a prostate will get prostate cancer, but estimates suggest that 1 in 8 will at some point in their lifetime. The prostate is a gland that plays a role in ejaculation. While ...

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the ...

Some men in England with the disease will now be offered an advanced form of treatment on the NHS.